1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
EpiCast Report: Benign Prostatic Hyperplasia - Epidemiology Forecast to 2024

EpiCast Report: Benign Prostatic Hyperplasia - Epidemiology Forecast to 2024

  • September 2015
  • 28 pages
  • ID: 3331242
In this report:
In the ##MM, adults ages ##-## years had the highest number of diagnosed prevalent cases of BPH in 2014, with ##,##,## diagnosed prevalent cases (##.##% of all diagnosed prevalent cases), closely followed by adults ages ##-## years with ##,##,## diagnosed prevalent cases (##.##% of all diagnosed prevalent cases).

Summary

Table of Contents

Search Inside

EpiCast Report: Benign Prostatic Hyperplasia - Epidemiology Forecast to 2024

Brief

Benign prostatic hyperplasia is a nonmalignant growth of prostatic tissue that surrounds the urethra, and leads to constriction of the urethral opening, which gives rise to lower urinary tract symptoms. BPH is commonly observed in men ages 40 years and above. The diagnosis of BPH is made on clinical basis by the presence of LUTS and benign prostatic enlargement and the absence of any other identifiable causes.

The diagnosed prevalent cases of BPH in the 7MM increased from 16,095,043 cases in 2014 to 18,884,244 cases in 2024, at an annual increase rate of ~1.7 percent during the forecast period. Among the 7MM in 2024, the U.S. will have the more significant number of diagnosed prevalent cases of BPH, with 6,182,362 diagnosed prevalent cases, whereas Spain (ES) will have the lowest number, with 1,599,508 diagnosed prevalent cases. In the 5EU, Germany (DE) will have the more important number of diagnosed prevalent cases of BPH in 2024, with 2,512,517 diagnosed prevalent cases, and Spain (ES) will have the lowest number, with 1,599,508 diagnosed prevalent cases.

GlobalData's epidemiological analysis offers a country-specific forecast for the diagnosed prevalent cases of BPH in the 7MM during 2014-2024.To construct the 10-year epidemiological forecast for the diagnosed prevalent cases of BPH in the 7MM, GlobalData epidemiologists used data available from population based studies in the 7MM. For the U.S., GlobalData epidemiologists used data available from a study that provided a nationally representative number of diagnosed BPH cases in the US men, which was farther split into the age-specific diagnosed BPH cases. GlobalData epidemiologists used the data available from population based studies in the United Kingdom (UK) and Italy (IT) to calculate the diagnosed prevalence of BPH in the 5EU. Due to lack of data on the diagnosed prevalence of BPH in Japan (JP), GlobalData epidemiologists used a study from Korea and applied the age-specific distribution of histological prevalence from a US study to calculate the age-specific diagnosed prevalence of BPH in Korea, and then used it as proxy for Japan (JP).

Overview

- The benign prostatic hyperplasia EpiCast Report offers an overview of the risk factors, comorbidities, and overall trends for Benign Prostatic Hyperplasia in the seven main markets (7MM) (US, France (FR), Germany (DE), Italy (IT), Spain (ES), UK, Japan (JP)). It includes a 10-year epidemiological forecast of the diagnosed prevalent cases of BPH divided by age (10-year intervals starting at ages 40 years and ending at =85 years). The diagnosed prevalent cases of BPH were broken down into mild, moderate, and severe categories as per the IPSS criteria defined by the American Urological Association.

- The BPH epidemiology report is were written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is detailed, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Great reasons to purchase

- Develop strategic management by understanding the trends shaping and driving the overall BPH market.

- Quantify patient populations in the overall BPH market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and disease severity category that present the best opportunities for BPH therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Aneurysmal Subarachnoid Hemorrhage (aSAH) - Market Insights, Epidemiology and Market Forecast-2027

Aneurysmal Subarachnoid Hemorrhage (aSAH) - Market Insights, Epidemiology and Market Forecast-2027

  • $ 6250
  • Industry report
  • October 2018
  • by Delve Insight

DelveInsight’s ‘Aneurysmal Subarachnoid Hemorrhage (aSAH) - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted ...

Podiatry Services Global Market Strategies and Opportunities to 2021

Podiatry Services Global Market Strategies and Opportunities to 2021

  • $ 4000
  • Industry report
  • July 2018
  • by The Business Research Company

Podiatrists are physicians or surgeons specializing in preventing, diagnosing and treating conditions of lower extremities such as feet and ankle.Podiatrists offer comprehensive care for all situations ...

Podiatry Services Global Market Opportunities And Strategies To 2021

Podiatry Services Global Market Opportunities And Strategies To 2021

  • $ 4000
  • Industry report
  • July 2018
  • by The Business Research Company

Podiatry Services Global Market Opportunities And Strategies By Speciality: General Podiatry, Podiatric Surgery, Sports Medicine, Podopaediatrics; By Treatment Condition: Diabetes, Musculoskeletal Diseases, ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on